» Articles » PMID: 28434145

MTORC1 Signaling in Hepatic Lipid Metabolism

Overview
Journal Protein Cell
Date 2017 Apr 24
PMID 28434145
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanistic target of rapamycin (mTOR) signaling pathway regulates many metabolic and physiological processes in different organs or tissues. Dysregulation of mTOR signaling has been implicated in many human diseases including obesity, diabetes, cancer, fatty liver diseases, and neuronal disorders. Here we review recent progress in understanding how mTORC1 (mTOR complex 1) signaling regulates lipid metabolism in the liver.

Citing Articles

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment.

Pu S, Zhao B, Jiang Y, Cui X Lipids Health Dis. 2025; 24(1):75.

PMID: 40016726 PMC: 11866868. DOI: 10.1186/s12944-025-02474-0.


Melanocortin 3 receptor regulates hepatic autophagy and systemic adiposity.

Patel T, Jun J, Seo A, Levi N, Elizondo D, Chen J Nat Commun. 2025; 16(1):1690.

PMID: 39956805 PMC: 11830824. DOI: 10.1038/s41467-025-56936-1.


miR-141-3p inhibited BPA-induced proliferation and migration of lung cancer cells through PTGER4.

Ling F, Xie W, Kui X, Cai Y, He M, Ma J Cytotechnology. 2025; 77(1):28.

PMID: 39741890 PMC: 11683044. DOI: 10.1007/s10616-024-00692-5.


IPEC-J2 Autophagy Induced by TLR4 and NSP6 Interactions Facilitate Porcine Epidemic Diarrhea Virus Replication.

Zhao H, Zheng D, Chang Q, Zhang H, Shao Y, Li J Viruses. 2024; 16(11).

PMID: 39599901 PMC: 11598845. DOI: 10.3390/v16111787.


Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases.

Nie S, Zhang S, Wu R, Zhao Y, Wang Y, Wang X Front Pharmacol. 2024; 15:1470879.

PMID: 39575387 PMC: 11578714. DOI: 10.3389/fphar.2024.1470879.


References
1.
Potter C, Pedraza L, Xu T . Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 2002; 4(9):658-65. DOI: 10.1038/ncb840. View

2.
Heitman J, Movva N, Hall M . Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991; 253(5022):905-9. DOI: 10.1126/science.1715094. View

3.
Kunz J, Henriquez R, Schneider U, Movva N, Hall M . Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell. 1993; 73(3):585-96. DOI: 10.1016/0092-8674(93)90144-f. View

4.
Yecies J, Zhang H, Menon S, Liu S, Yecies D, Lipovsky A . Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011; 14(1):21-32. PMC: 3652544. DOI: 10.1016/j.cmet.2011.06.002. View

5.
Liu P, Gan W, Inuzuka H, Lazorchak A, Gao D, Arojo O . Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol. 2013; 15(11):1340-50. PMC: 3827117. DOI: 10.1038/ncb2860. View